4DMedical

4DX · ASX · AUD

$4.23−2.53%−$0.11

Close · October 5, 2026

Valuation

Data as of October 4, 2026

Valuation multiples

Market cap: $2.61B
Enterprise value: $2.51B
Forward P/E: -222.6
Price/book: 15.2
Price/sales: 369.7
EV/EBITDA: -44.9
EV/revenue: 355.9

Profitability and growth

Gross margin: 93.8%
Operating margin: -735.1%
Net margin: 0.0%
ROE: -174.4%
ROA: -15.6%
Revenue growth (year over year): 42.3%

Financial health

Total cash: $277.95M
Total debt: $180.24M
Debt/equity: 1.06
Current ratio: 30.8
Quick ratio: 30.5

Dividends

Payout ratio: 0.0%

Analysts and estimates

Average price target: $4.37
Median price target: $4.10
High price target: $6.00
Low price target: $3.00
Analysts with a price target: 3
Consensus: Hold
Forward EPS: -$0.02
EPS estimate, current year: -$0.06

Shares and trading

Beta: 1.95
Average volume: 4.81M
Shares outstanding: 601.59M
Float: 498.92M
Institutional ownership: 23.9%
Insider ownership: 16.6%